HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and biological evaluation of 68Ga labeled bis-DOTA-3,3'-(benzylidene)-bis-(1H-indole-2-carbohydrazide) as a PET tracer for in vivo visualization of necrosis.

Abstract
The aim of the present study was to develop a (68)Ga labeled bis-DOTA derivative of benzylidene-bis-indole and compare the in vivo stability and biodistribution with that of the previously reported bis-DTPA derivate for in vivo imaging of necrosis using PET. Uptake of the tracer was evaluated in a mouse model of Fas-mediated hepatic apoptosis in correlation with histochemical stainings. The novel (68)Ga labeled tracer showed an improved in vivo stability and could therefore be used for selective non-invasive imaging of necrotic cell death using PET.
AuthorsKristof Prinsen, Marlein Miranda Cona, Jan Cleynhens, Hubert Vanbilloen, Junjie Li, Natalia Dyubankova, Eveline Lescrinier, Guy Bormans, Yicheng Ni, Alfons Verbruggen
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 23 Issue 11 Pg. 3216-20 (Jun 01 2013) ISSN: 1464-3405 [Electronic] England
PMID23635829 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013. Published by Elsevier Ltd.
Chemical References
  • Coordination Complexes
  • Fas protein, mouse
  • Gallium Radioisotopes
  • Heterocyclic Compounds, 1-Ring
  • Radiopharmaceuticals
  • fas Receptor
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Pentetic Acid
Topics
  • Animals
  • Apoptosis (drug effects)
  • Coordination Complexes (chemical synthesis, pharmacokinetics, toxicity)
  • Gallium Radioisotopes (chemistry)
  • Half-Life
  • Heterocyclic Compounds, 1-Ring (chemistry)
  • Mice
  • Necrosis (diagnostic imaging)
  • Pentetic Acid (chemistry)
  • Positron-Emission Tomography
  • Radiopharmaceuticals (chemical synthesis, pharmacokinetics, toxicity)
  • Tissue Distribution (drug effects)
  • fas Receptor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: